Silencing hypoxia-inducible factor-1α inhibits cell migration and invasion under hypoxic environment in malignant gliomas

International Journal of Oncology

Volumn 30, Issue 4, 2007, Pages 793-802

  Fujiwara, Satoshi ^a   Nakagawa, Kou ^a   Harada, Hironobu ^a   Nagato, Shigeyuki ^a   Furukawa, Koji ^a   Teraoka, Mikio ^a   Seno, Toshimoto ^a   Oka, Keizo ^b   Iwata, Shinji ^a   Ohnishi, Takanori ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

Glioma; Hypoxia; Hypoxia inducible factor 1 ; Invasion; siRNA

Indexed keywords

GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANOXIA; ARTICLE; BRAIN TUMOR; CANCER INVASION; CELL MOTION; DOWN REGULATION; DRUG ANTAGONISM; GENETICS; GLIOMA; HUMAN; METABOLISM; PATHOLOGY;

ANOXIA; BRAIN NEOPLASMS; CELL MOVEMENT; DOWN-REGULATION; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 34247847903     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.4.793     Document Type: Article

References (41)

1. Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103, 2000.
2. Wenger RH: Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 16: 1151-1162, 2002.
3. Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
4. Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, Katschinski DM and Wenger RH: The hypoxia-inducible factor-1 alpha is negative factor for tumor therapy. Oncogene 22: 3213-3220, 2003. (Pubitemid 36712933)
5. Brown JM and Giaccia AJ: The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416, 1998.
6. Hockel M, Schlenger K, Hockel S and Vaupel P: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59: 4525-4528, 1999. (Pubitemid 29428951)
7. Vaupel P, Thews O and Hoeckel M: Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18: 243-259, 2001. (Pubitemid 34044509)
8. Sondergaad KL, Hilton DA, Penney M, Ollerenshaw M and Demaine AG: Expression of hypoxia-inducible factor 1 alpha in tumours of patients with glioblastoma. Neuropathol Appl Neurobiol 28: 210-217, 2002. (Pubitemid 34639443)
9. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW and Semenza GL: Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88: 2606-2618, 2000. (Pubitemid 30331970)
10. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
11. Ohnishi T, Arita N and Hayakawa T: Motility factor produced by malignant glioma cells: role in tumor invasion. J Neurosurg 73: 881-888, 1990.
12. Ohnishi T, Arita N and Hiraga S: Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis 15: 538-546, 1997. (Pubitemid 27323903)
13. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA and Kozlowski JM: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987. (Pubitemid 17082655)
14. Amer AP, De Armond SJ, Spencer DR, Coopersmith PF, Ramos DM and Rosenblum ML: Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion. J Neurooncol 20: 1-15, 1994.
15. Ohnishi T, Arita N, Hayakawa T, Kawahara K, Kato K and Kakinuma A: Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion. Biochem Biophys Res Commun 193: 518-525, 1993. (Pubitemid 23214257)
16. Schor SL, Schor AM and Winn B: The use of three-dimensional collagen gels for the study of tumor cell invasion in vitro: experimental parameters influencing cell migration into the gel matrix. Int J Cancer 29: 57-62, 1982.
17. Ohnishi T, Matsumura H, Izumoto S, Hiraga S and Hayakawa T: A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58: 2935-2940, 1998. (Pubitemid 28335065)
18. Stoppini L, Buchs PA and Muller D: A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182, 1991.
19. Murakami M, Goto S, Yoshikawa M, Goto T, Hamasaki T, Rutka JT, Kuratsu J and Ushio Y: The invasive features of glial and non-central nervous system tumor cells are different on organotypic brain slices from newborn rats. Int J Oncol 18: 721-727, 2001.
20. Horan PK, Melnicoff MJ, Jensen BD and Slezak SE: Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol 33: 469-490, 1990.
21. Chomczynski P and Sacchi N: Single step method of RNA isolation by acidic guanidinium thiocyanate ohenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Davies B, Miles DW and Happerfield LC: Activity of type I collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993. (Pubitemid 23147516)
23. Nagato S, Nakagawa K, Harada H, Kohno S, Fujiwara H, Sekiguchi K, Ohue S, Iwata S and Ohnishi T: Downregulation of laminin alpha4 chain expression inhibits glioma invasion in vitro and in vivo. Int J Cancer 117: 41-50, 2005. (Pubitemid 41262758)
24. Hockel M and Vaupel P: Tumor hypoxia definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276, 2001. (Pubitemid 32219813)
25. Gregg LS: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
26. Zhou J, Schmid T, Schnitzer S and Brune B: Tumor hypoxia and cancer progression. Cancer Lett 237: 10-21, 2006.
27. Liotta LA, Rao CN and Wewer UM: Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem 55: 1037-1057, 1986. (Pubitemid 16070794)
28. Paetau A, Mellstom K, Vaheri A and Haltia M: Distribution of a major connective tissue protein, fibronectin, in normal and neoplastic human nervous tissue. Acta Neuropathol 51: 47-51, 1980. (Pubitemid 10080531)
29. Rutka JT, Apodaca G, Stern R and Rosenblum M: The extracellular matrix of the central and peripheral nervous systems: structures and function. J Neurosurg 69: 155-170, 1988.
30. Matsumura H, Ohnishi T, Kanemura Y, Maruno M and Yoshimine T: Qunatitative analysis of glioma cell invasion by confocal laser scanning microscopy in a novel brain slice model. Biochem Biophys Res Commun 269: 513-520, 2000. (Pubitemid 30440332)
31. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
32. Nakano A, Tani K, Miyazaki Y, Yamamoto J and Furuyama I: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995.
33. VanMeter TE, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC and Pilkington GJ: The role of matrix metalloproteinase gene in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53: 213-235, 2001.
34. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL and Rao JS: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56: 384-392, 1996.
35. Raithatha SA, Muzik H, Muzik H, Rewcastle NB, Johnston RN, Edwards DR and Forsyth PA: Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neurooncol 2: 145-150, 2000.
36. Jiang BH, Agani F, Passaniti A and Semenza GL: V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57: 5328-5335, 1997.
37. Laughner E, Taghavi P, Chiles K, Mahon PC and Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21: 3995-4004, 2001.
38. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
39. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW and Semenza GL: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541-1545, 2000.
40. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D and Giaccia AJ: Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14: 391-396, 2000.
41. Furukawa K, Kumon Y, Harada H, Kohno S, Nagato S, Teraoka M, Fujiwara S, Nakagawa K, Hamada K and Ohnishi T: PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules. Int J Oncol 29: 73-81, 2006.